Douglas, Katie M.
Inder, Maree L.
Crowe, Marie T.
Jordan, Jennifer
Carlye, Dave
Lacey, Cameron
Beaglehole, Ben
Mulder, Roger
Eggleston, Kate
Donovan, Katherine A.
Frampton, Christopher M. A.
Bowie, Christopher R.
Porter, Richard J.
Funding for this research was provided by:
Health Research Council of New Zealand (19/082)
Article History
Received: 11 January 2022
Accepted: 1 February 2022
First Online: 14 February 2022
Declarations
:
: Ethics approval for the current study protocol (19/NTB/54) was granted on 16 May 2019 from the New Zealand Health and Disability Ethics Committees (HDEC, Northern B), Ministry of Health, 133 Molesworth Street, P.O. Box 5013, Wellington 6011, New Zealand. All participants provided written informed consent. Any modifications to the study protocol will be communicated to the HDEC and updated on the trial registry.
: Not applicable.
: KD, RP, and CB use software for research at no cost from Scientific Brain Training Pro. RP has received support for travel to educational meetings from Servier and Lundbeck. CB is a Consultant or Board Member for Takeda, Boehringer Ingelheim, Lundbeck, Otsuka and receives grant Support from Pfizer, Takeda. All other authors have no competing interests to declare.